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Evaluation of the Anticancer Activity of
Bioactive Fraction G Extracted from Pavetta
crassipes in Malignant Brain Tumor Cell Lines
Abstract
Objective: Natural products have served as sources of lead compounds that are
commonly used in the treatment of human diseases including cancer. Pavetta
crassipes has been widely demonstrated to have ethnopharmacological potential
in the management of malaria, gastrointestinal conditions, central nervous system
behavioral disorders, hypertension, and cancer. The goal of our study was to
evaluate the biological and molecular effects of Fraction G, obtained from the
plant Pavetta crassipes, on glioblastoma invasive growth and survival.
Methodology: The antiproliferative effects of Fraction G, obtained from Pavetta
crassipes, was evaluated using the trypan blue exclusion, (3-(4, 5-Dimethylthiazol2yl)-2, 5-Diphenyltetrazolium Bromide; MTT), and lactate dehydrogenase (LDH)
assays. Flow cytometry and Western blotting analyses were carried out to examine
the effects of Fraction G on cell cycle check-points and its effects on epidermal
growth factor receptor-mediated signaling of AKT and MAPK pathways.
Results: In this paper, we report that the Fraction G obtained from the plant Pavetta
crassipes induced a reduction in glioma cell viability and proliferation as well as
induced an increase in apoptosis as evidenced by cleaved PARP, increased caspase
3/7 activity, and cell cycle arrest in the G0/G1 check point. Furthermore, we report
that Fraction G inhibited the phosphorylation of AKT and MAPK following EGF
treatment.
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Conclusion: Taken together, our results demonstrate that Fraction G has potent
inhibitory effects on pathways involved in glioblastoma proliferation and survival.
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Introduction
Glioblastoma multiforme (GBM) is the most common and deadly
type of malignant brain tumor that affects adults. The patient
survival rates are low, with less than 5% of patients surviving 5
years [1,2]. The average life expectancy of patients with GBM is
only slightly over 1 year, even with current treatment options
[3]. According to the World Health Organization (WHO), GBM is
classified into four different tumor grades with class IV being the
most aggressive and also the most common type of tumor [4].
GBM can also be categorized as primary or secondary tumors.
Even though primary GBM are rapid growing while secondary
tumors tend to arise slower, they are almost indistinguishable,
resistant to current available therapies, and have a poor prognosis
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[5]. Dysregulated expression of several important growth factors,
survival and cell cycle regulators have been implicated as major
contributing factors to GBM’s invasiveness, rapid growth, and
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resistance to chemotherapy. Such molecular targets include
the Epidermal Growth Factor Receptor (EGFR), Platelet Derived
Growth Factor Receptor (PDGFR), and the Vascular Endothelial
Growth Factor (VEGF) [6-8]. Overexpression of EGFR occurs in
about half of primary glioblastoma cases and correlates with
decreased overall survival of GBM patients. Most brain tumors
that overexpress EGFR also overexpress the active mutant
variant, with a frequency of ~40–50%. The mutant form has been
shown to confer a less favorable prognosis for GBM patients
[9]. Once dysregulated and activated, it activates downstream
protein targets, such as PI3K/AKT/mTOR and Ras-Raf-MEK-ERK.
These signaling pathways are known to promote tumor growth
and survival [10,11]. Although several treatment options exist, a
whole host of problems including cost, drug resistance and toxicity,
and the inability to surgically remove all cancerous cells pose a
significant barrier to current available therapy and strategies. The
need for newer effective, and less toxic therapeutic agents and
strategies cannot be over emphasized. Greater than 50% of drugs
currently used as chemotherapeutic agents are of natural product
origin [11] and some of these include Camptotheca alkaloids,
Vinca alkaloids, Taxus diterpenes, and Podophyllum lignans.
Natural products of plant and animal sources are known to serve
as an important source of new chemical entities and drugs with
potential therapeutic benefits [12]. The research into plants that
are employed to treat a number of diseases including “cancer” in
traditional ethnomedicine is therefore one of the productive and
logical strategies in the search for new therapeutic agents [13].
The leaves of the Pavetta crassipes K. Schum (Rubiaceae) plant
are used for food as well as medicinally in African countries to
treat a wide variety of diseases and illnesses, such as respiratory,
cardiovascular, central nervous system and cancer [14-17]. In this
study, we seek to determine and evaluate the biological effects
of Pavetta crassipes bioassay guided fractions on malignant
glioblastoma cells and the molecular signaling pathways
perturbed by Fraction G.

Materials and Methods
Plant material
The leaves of P. crassipes K. Schum (Rubiaceae) were harvested
fresh from a horticultural garden in Abuja, FCT, Nigeria, and
were air-dried. The plant was botanically identified by Dr. Grace
Ugbabe, and a voucher sample (number 4745) was deposited in
the department of Medicinal and Traditional Medicine, National
Institute for Pharmaceutical Research and Development (NIPRD),
Abuja, Nigeria.

Extraction of plant material
The air-dried leaves were finely powdered, and a 500 g portion
of the plant material was macerated at room temperature with
2 L of methanol (MeOH) for 24 hours. The mixture was filtered
and the filtrate evaporated (40°C) in vacuo until MeOH was
almost removed. The methanolic extract was dried in a vacuum
desiccator to yield a dry powder of 75 g.

Bioassay guided fractionation of P. crassipes extracts
Ten grams of the methanolic extract was loaded on a flash
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chromatography column packed with 200 g of silica gel (230-400
mesh size). The column was successively eluted with petroleum
ether 100%, petroleum ether/ethyl acetate 7:3; petroleum ether/
ethyl acetate 3:7, ethyl acetate 100%, and ethyl acetate methanol
9:1. Thirty-nine (39) fractions of 50 mL each were collected.
Fractions were monitored with thin layer chromatography (TLC).
Fractions showing similar compounds on the TLC were combined.
Five (5) pooled fractions labeled fraction A, fraction C, fraction E,
fraction G and fraction J were collected and sent for biological
screening. Fraction G, eluted with 100% ethyl acetate, was found
to be biologically active. Fraction G was further analyzed using
Ultra High Performance Liquid Chromatography (UHPLC).

UHPLC chromatography of fraction G
A Dionex Ultimate 3000 UHPLC instrument equipped with a
quaternary analytical pump, an autosampler with integrated
column compartment, a diode array detector, and an automated
fraction collector was used. Columns utilized included an Acclaim
120 C18 guard column (4.6 × 10 mm, 5 µm silica) and an Acclaim
120 C18 analytical column (4.6 × 150 mm, 5 µm silica). The
mobile phase was composed of 65% methanol and 35% water
(containing 1% glacial acetic acid). The sample was dissolved in
the mobile phase at a concentration of 1 mg/mL. The analysis
was performed at a temperature of 30°C, flow rate of 1.0 mL/min
and injection volume of 10 µL. Peaks were monitored at 223, 230,
254 and 365 nm.

Cell lines
Human glioblastoma cell lines (U251 MG, U1242 MG) and
Normal Human Astrocytes (NHAs) were kind gifts from Dr. Isa
Hussaini, University of Virginia, Charlottesville, USA. The cells
were cultured in MEM-alpha (Life Technologies, Fisher Scientific,
Pittsburgh, PA), supplemented with 10% FBS (Biowest, Kansas,
MO), 1% penicillin and streptomycin (Fisher Scientific, Pittsburgh,
PA). Prior to experimental studies and assays, cultures were
grown to 70-80% confluency. These cells were serum starved and
treated with Fraction G in the presence or absence of EGF (25 ng/
mL).

Chemicals and reagents
EGF and anti-tubulin antibody (DM1A) were purchased from
Sigma Aldrich (St. Louis, MO), phospho-specific and total
antibodies directed against ERK ½, and AKT, were obtained from
Cell Signaling Technologies (Beverly, MA), antibody directed
against PARP was obtained from Trevigen (Gaithesburg, MD). MTT
(3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide)
was purchased from Promega (Madison, WI). 0.4% Trypan blue
stain was obtained from Gibco Life Technologies (Grand Island,
NY). Pierce LDH cytotoxicity assay kit was obtained from Thermo
Scientific (Rockford, IL).

Cell counts using Trypan blue exclusion assay
GBM cell lines U251 MG and U1242 MG were seeded at 1 ×
105 cells per well in a 6 well plate in the presence or absence
of Fraction G (0-20 µg/mL) for 0-72 h. Treated and untreated
cells were trypsinized and harvested every 24 h. 100 μL of cell
suspension was pipetted into a microcentrifuge tube and mixed
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with 100 μL of Trypan blue dye. 20 μL of cell suspension was
added to a hemocytometer slide and the cells were counted
under a microscope [18]. In another set of experiments, we
tested the effects of Fraction G on non-malignant, normal human
astrocytes (NHA). NHAs were grown on glass slides in a 6 well
plate. After reaching 70% confluency, the cells were treated with
DMSO (control) and Fraction G (10 µg/mL) for 48 h. The cells
were washed with PBS and photographed using a NIKON H600L
Eclipse, Japan fluorescence microscope.

Assessment of cell viability
This test was carried out to assess the effects of fraction G on
glioma cell proliferation using the MTT assay. The MTT assay is
based on the ability of cells to metabolize a yellow tetrazolium
salt to a formazan product that can be detected using a
spectrophotometer. Briefly, GBM cells were seeded at 5 × 103
cells in a 96-well plate and incubated for 24 h. The cells were
then treated with various concentrations of Fraction G (0-20
µg/mL) for 48 and 72 h. Following Fraction G exposure, 20 µL
of MTT reagent was added to the 96-wells containing cells and
culture media (100 µL) and the plates were incubated at 37 °C
in a humidified atmosphere containing 5% carbon dioxide for 4
h. At the end of the 4 h incubation period, the cell solubilization
and stop reagent was added at a volume of 100 µL for 60 min.,
kept in the dark at room temperature and the optical density
was measured using Promega Glomax Multidetection System
(Madison, WI). The optical density was used to calculate the rate
of cell proliferation after exposure to the different concentrations
of Fraction G compared to the control wells. All experiments were
performed in triplicate and the mean ± SEM for each experiment
was calculated and plotted as a bar graph [19,20].

Cell cycle analysis by flow cytometry
The flow cytometric analysis of U251 glioma cells was performed
using the Becton Dickinson FACScalibur (BD Biosciences, San
Jose, CA) equipped with CellQuest software. U251 MG cells were
plated in 10 cm plates. After 24 h the cells were serum starved and
treated with varying concentrations of Fraction G (0-20 µg/mL)
for 72 h. After the 72 h treatment, the floating and adherent cells
were pooled together. The cell suspension was then centrifuged
at 800 x g. Cell pellets were resuspended, washed with PBS, fixed
in ice-cold 70% ethanol and stored at -20°C. The fixed cells were
washed with PBS and stained with a solution consisting of PBS
with 20 µg/mL of propidium iodide from Sigma, (St. Louis, MO),
0.1% Triton X-100 and 200 µg/mL RNAse A (Sigma, St. Louis, MO),
kept in the dark for 1 h. The stained cells were analyzed using
the BD FACScalibur equipped with CellQuest software. For each
sample 20,000 counts were analyzed. Cells were gated using the
Cellquest software to estimate the proportion of cells distributed
as a percentage in the different cell cycle compartments [21].

Detection of apoptotic cells
Living and dead glioma cells were detected using fluorescence
microscopy. In this assay, GBM cells were cultured on coverslips
© Under License of Creative Commons Attribution 3.0 License
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and treated with varying concentrations of Fraction G (0, 5-20
µg/mL) for 72 h. At the end of the treatment time point, cells
were washed with PBS and stained with the Hoechst 33342 (10
µg) for live cells and PI (10 µg) for dead cells. Hoechst 33342 dye
penetrates the membrane and therefore, has the potential to
stain live cells. This stain is known to bind the adenine-thymineregions of the DNA. The fluorescence of Hoechst dye is very
sensitive to DNA changes in cells. This dye can detect changes of
nuclear compromise and damage. Hoechst 33342 dye emits blue
fluorescence when bound to double-stranded DNA. This dye is
often used to distinguish condensed nuclei in apoptotic cells. The
propidium iodide dye is an impermeant dye that is often excluded
from the living and viable cells. PI dye is known to penetrate cells
with compromised or damaged membrane. The stained cells
were placed in the dark for 10 min at room temperature. Images
of cells were photographed using the NIKON H600L Eclipse, Japan
fluorescence microscope [22,23].

Lactate Dehydrogenase (LDH) assay
The release of lactate dehydrogenase (LDH) is indicative of
compromised membrane integrity and cell injury. The assay
protocol outlined by Trevor et al. [24] was used in this study with
some modifications. GBM cells (U251 MG and U1242 MG) were
treated with Fraction G for 48 h. After treatment, cellular amount
of LDH was measured by adding lysis buffer (1% Triton) to the cells.
The amount of LDH content released by the cells was measured
using Promega Glomax Multi-detection system microplate reader
at a wavelength of 490 nm. The data obtained are represented as
mean ± SEM of three independent experiments.

Measurement of caspase 3/7 activity
Caspase activity was detected as a means to evaluate apoptosis
in cells treated with fraction G. Cells were assayed for Caspase
3/7 activity 48 h after fraction G treatment using Caspase 3/7
Glo substrate solution as recommended by the manufacturer
(Promega, Madison, WI). Luminescence was measured using
a Glomax multidetector system (Promega, Madison, WI).
Luminescence readings were corrected by cell number and also
compared to protein concentration via BCA (Thermo Scientific
(Rockford, IL). Values shown are normalized to a percent maximal
activity. In another set of experiments, a broad spectrum caspase
inhibitor was used to rescue the effect of fraction G on upregulation of caspase cleavage. Glioma cell lines were pretreated
with the caspase inhibitor Ac-DEVD-CHO (100 µM) for 4 hours
and then treated with fraction G for 48 h. After a 48 h time point,
the cells were counted using the hemocytometer.

Western blot analysis
Immunoblotting analyses were carried out as previously reported
[25,26]. After the different treatments, cells were washed in ice
cold PBS and extracted with 1% Triton X-100 cell lysis buffer.
Cells were centrifuged at 14,000 x g for 10 min at 4°C. Protein
concentrations of the supernatant were determined by the BCA
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protein assay (Bio-Rad). Proteins were subjected to electrophoresis
and separated by SDS-PAGE on 10% polyacrylamide gels and then
electroblotted onto nitrocellulose. The nitrocellulose membranes
were incubated with primary antibody overnight at 4°C. These
membranes were washed three times with phosphate buffered
saline with tween 20 (PBST) and incubated with a peroxidase
conjugated secondary antibody (Jackson ImmunoResearch Lab,
West Grove, PA) at room temperature. After the secondary
antibody, the membranes were washed and protein visualization
was carried out using the enhanced chemiluminescence (ECL)
reagents from Fisher Scientific (Milwaukee, WI) as described
by the manufacturer. In sets of experiments investigating
PARP cleavage, glioma cell lines were treated with different
concentrations of fraction G, floating cells as well as the adherent
cells were pooled together and centrifuged at 800 × g. The media
was decanted and the cell pellet was extracted with RIPA buffer.
The cell suspension was then sonicated and centrifuged at 14,000
× g for 10 min at 4 °C. Proteins (20 µg/lane) were separated by
SDS-PAGE on 10% or 12% polyacrylamide gels, then transferred
onto nitrocellulose and reacted with antibodies directed against
PARP. Experiments were repeated three times for reproducibility.
Densitometry and ImageQuant were carried out using the Alpha
Innotech FluorChem2 (Cell Biosciences, Santa Clara, CA).

2017
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Results
HPLC analysis of fraction G
The HPLC finger print data revealed that Fraction G was a mixture
of several compounds as seen in Figure 1.

Effect of fraction G from Pavetta crassipes leaves
on glioma cell proliferation
We employed the MTT assay to determine the effects of Fraction G
on GBM cell proliferation and viability. The MTT assay is based on
the cells ability to convert tetrazolium salt to insoluble formazan.
A decrease in cellular accumulation of formazan indicates a
damage in cells (loss of viable cells) or cytostatic activity. Our
results revealed that fraction G induces a dose-dependent
decrease in the formation of formazan by the glioma cell lines
tested (U251 MG (Figure 2A) and U1242 MG (Figure 2B)). EGF
is known to stimulate pathways that increase cell proliferation,
survival and migration in glioblastoma. We tested the effects of
Fraction G on EGF induced cell proliferation and viability using
the MTT assay in GBM cells. The addition of 25 ng/mL EGF
induced a robust increase in GBM cell proliferation. Fraction G
concentration-dependently abrogated EGF-mediated increase in
cell proliferation in U251 (Figure 2C) and U1242 (Figure 2D).

Statistical analysis

Effect of fraction G from Pavetta crassipes leaves
on glioma cell viability

Data are expressed as mean ± SEM. All statistical analyses were
performed with GraphPad Prism 7 software using the one-way
analysis of variance followed by the Bonferroni test. A value of
p<0.05 was considered to be statistically significant.

The MTT test above suggests that Fraction G decreased the
viability of U1242 MG and U251 MG cells. To confirm these
effects, we examined the effects of Fraction G on U1242 MG and
U251 MG cell viability using the Trypan blue exclusion and lactate

Figure 1 Chromatogram of Fraction G from Pavetta crassipes extracts.
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Figure 2 Effects of fraction G (0-20 µg/mL) on the proliferation of (a) U251 MG cells as measured by a MTT assay after 48 h of treatment. (b).
Effects of fraction G (0-20 µg/mL) on the proliferation of U1242 MG cells as measured by a MTT assay after 48 h of treatment. (c).
Effects of fraction G (0-20 µg/mL) on EGFR-mediated cell proliferation in U251 MG cells. (d). Effects of fraction G (0-20 µg/mL) on
EGFR-mediated cell proliferation in U1242 MG. All data are expressed as the mean ± SD of experiments. *Denotes significant (p<0.05)
difference in proliferation of treated cells compared to untreated control cells.

dehydrogenase (LDH) assays. Trypan blue exclusion is based on
the principle that live cells possess intact cell membranes and
will exclude trypan blue, while dying cells possess compromised
cell membranes and thus will not exclude dye. We observed that
both U1242 MG and U251 MG treated with Fraction G (0-20
µg/mL) showed a dose- and time-dependent increase in trypan
blue positivity (Figure 3A and 3B) compared with cells treated
with control medium. We also tested the ability of fraction G to
cause changes in cell membrane integrity and leakage of lactate
dehydrogenase (LDH) into extracellular media on U1242 MG and
U251 MG. U1242 MG and U251 MG cells treated with Fraction
G dose-dependently displayed an increased in the amount of
lactate released into culture media after 48 h when compared
to control cells (Figure 3C and 3D). Our data shows that Fraction
G dose dependently decreased GBM cell viability. Futhermore,
we investigated the effects of Fraction G on the viability of nonmalignant normal human astrocytes. We observed from the
pictograph that treatment with fraction G (10 µg/mL) did not
alter the morphology of the cells (Figure 3E).

Effect of fraction G from Pavetta crassipes leaves on
glioma cell cycle
Since the MTT test does not distinguish cellular proliferation from
death, we employed cellular number counts and fluorescent
activated cell sorting (FACS) to ascertain the effects of Fraction G on
© Under License of Creative Commons Attribution 3.0 License

GBM cell cycle check points. Flow cytometric analysis revealed that
Fraction G significantly increased the percentage of cells arrested in
G0/G1 cell cycle check point with fragmented nuclei when compared
to control treated cells (Figure 4A). Our data showed that 18.94% of
control cells were arrested while cells treated with Fraction G had
an increase in arrested cells from 33.81% to 41.8% (Figure 4A).
We further tested the effects of Fraction G on U251 MG cells
and imaged both the dead and living cells using the Hoechst
33342 and propidium iodide. Our data in Figure 4B illustrates an
increase in the number of cells incorporating propidium iodide
with increase in the concentration of Fraction G.

The effect of fraction G from Pavetta crassipes
leaves on GBM cell death
To ascertain the mechanism of cell death induced by Fraction G
in U1242 MG and U251 MG cells, we measured PARP cleavage, a
well-known hallmark of apoptosis (33). We observed an increase
in the cleaved form of PARP from the active 116-kda DNA repair
molecule to the inactive 89-kda molecule in GBM cells treated
with a higher concentration of Fraction G when compared to
control cells (Figure 5A and 5B). Our data shows that Fraction
G induced apoptotic-dependent cell death of GBM cells. We
further investigated the effects of caspase activity, we show
here that fraction G induces a concentration dependent increase
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Figure 3 Effects of fraction G (0-20 µg/mL) on the viability of (a). U 251 MG cells after 24, 48 and 72 h of treatment (b). Effects of fraction G
(0-20 µg/mL) on the viability of U1242 MG cells after 24, 48, 72 h of treatment. (c) Cytotoxicity of fraction G (0-20 µg/mL) in U251
MG cells and (d) U1242 MG as measured by a LDH assay after 48 hours of treatment. (e) Pictograph showing the effects of Fraction
G on non-malignant NHA cells. All data are expressed as the mean ± SD of experiments performed in triplicate. *Denotes significant
(p < 0.05) difference in cell death in treated cells compared to untreated.

in caspase activity (Figure 5C and 5D). Our data also revealed
that both U1242 MG cells and U251 MG cells were sensitive to
Fraction G treatment. We attempt to rescue the observed cell
death induced by fraction G in glioma cell lines by pretreating the
cells with caspase inhibitor Ac-DEVD-CHO. Our data in Figure 5E
showed that pretreatment with the caspase inhibitor abrogated
the decrease in cell counts induced by fraction G.

The effect of fraction G from Pavetta crassipes
leaves on EGF-mediated activation of AKT and ERK
½ in GBM cells
To investigate the molecular mechanisms by which Fraction G
© Under License of Creative Commons Attribution 3.0 License

induces cell death and inhibits proliferation in GBM cells, we
investigated the effects of fraction G on EGF mediated activation
of MAPK and AKT. EGF binding to EGFR activates the Ras-RafMEK-ERK pathway which phosphorylates and activates ERK ½
downstream. AKT is activated by EGF through the PI3K/AKT/
mTOR pathway. Once activated, both AKT and ERK ½ can activate
other downstream signaling proteins that reduce apoptosis
and promote cell survival. Western blot analyses of U1242MG
and U251 MG cells treated with Fraction G attenuated EGFRmediated phosphorylation of AKT (Figure 6A and 6C) and ERK ½
(Figure 6B and 6D) in a concentration-dependent manner. These
data suggest that Fraction G interferes with EGF mediated effects
on the GBM cells by inhibiting the activation of ERK ½ and AKT.
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Figure 4 (A) Flow cytometry analyses for U251 MG cells treated with fraction G (0-20 µg/mL). After 72 hours, the cells were then stained with
propidium iodide and subjected to flow cytometry to analyze the cell cycle distribution. The table (insert) showed the percentage of
cells arrested at the G0/G1 cell cycle check point. (B) Effects of fraction G (0-20 µg/mL) on the morphology of U251 MG cells stained
with both propidium iodide and HOECHST 33342 (Magnification X10).
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Figure 5 (A) Western blot analyses showing the effects of fraction G (0-20 µg/mL) on the expression of cleavage of PARP in U251 MG cells
and (B) U1242 MG cells. Effects of fraction G on caspase 3/7 activity on (C) U1242 MG and (D) U251 MG cells after 48 h treatment.
(E) Effects of caspase inhibitor Ac-DEVD-CHO on U1242 MG and U251 MG cells treated with fraction G.

Figure 6 Western blot analyses showing the effects of fraction G (0-20 µg/mL) on EGF-induced phosphorylation of AKT in (A)
U251 MG and (C) U1242 MG cell lines. Western blot analyses showing the effects of fraction G (0-20 µg/mL) on EGFinduced phosphorylation of ERK1/2 in (B) U251 MG and (D) U1242 MG cell lines.
© Under License of Creative Commons Attribution 3.0 License
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Discussion
Medicinal plants have been used traditionally over the years
to treat several disease conditions and are still being used. The
resistance of cancer cells to current available chemotherapeutic
agents and the toxic side effects of these agents has prompted
scientists to further investigate the therapeutic potential of
natural agents. Even though many extracts from plants are
being investigated for their potential biological activities, it is
increasingly evident that the efficacy of these products require
their presence in a mixture of complex molecules rather than in
a pure single state [27,28]. With this thought in mind, we sought
to investigate the anticancer activity of Fraction G extract from
Pavetta crassipes leaves. We have previously reported that the
extract from Pavetta crassipes leaves possess some biological
CNS activities [16]. In this study we demonstrated that Fraction
G extract from Pavetta crassipes leaves has antitumor activity
against GBM cells, via its anti-proliferation, survival and its
potential to induce apoptosis. The anti-proliferative properties
of Fraction G occurred via the accumulation of these cells in the
G0/G1 phase of the cell cycle, while its pro-apoptotic properties
will most likely be through caspase activation since we observed
PARP cleavage. The ability of Fraction G to induce apoptosis as
preferred cell death makes it a potential tool for GBM therapy.
Various small molecules and therapeutic antibodies targeting
EGFR family members have been developed and are currently
used in the treatment of GBM. However, the increased use of
EGFR tyrosine kinase inhibitors has led to the development of
resistance to EGFR-targeting drugs due to targeted mutations and
the presence of EGFR-mutated variants. EGFR signaling plays a
key role in many cancers including glioblastoma. EGFR activation
of the RTK/RAS/PI3K pathway aids in the regulation of cellular
proliferation, angiogenesis, local tissue invasion and resistance to
apoptosis [29]. AKT provides key regulation of several cell survival,
growth and proliferation pathways. Additionally, changes in the
AKT pathway appear to play key roles in many types of cancer.
Thus this pathway has become a signaling pathway of interest to
target for cancer treatment [30]. Our data revealed that Fraction
G inhibited EGF mediated phosphorylation of AKT in glioma cell
lines. This data agrees with several studies that have shown
natural products downregulate AKT phosphorylation in gastric,
breast, brain, and other cancer cell lines [8,31]. Additionally,
the ERK pathway, one of several MAPK pathways, is known for
its role in cell proliferation. However, it is also understood to be
involved in other aspects of tumor presentation such as cellular
differentiation and migration [32-34]. Here we show that Fraction
G extract from Pavetta crassipes leaves inhibited EGF-mediated
ERK ½ phosphorylation.

Conclusion
The present study demonstrated that Fraction G possesses in vitro
biological activity against GBM cells by inhibiting cell proliferation
and inducing apoptosis. Our data also demonstrate that Fraction
G attenuated EGF-mediated phosphorylation of ERK ½ and AKT.
Additionally, we observed that treatment with Fraction G induced
PARP cleavage in two genetically different GBM cells. Fraction
G extract exhibited a dose and time dependent inhibition of
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EGF mediated GBM cell survival and proliferation. Therefore,
we conclude that Fraction G of the leaf extracts of P. crassipes
possess anti-tumor effects which possibly may be mediated via
the inhibition of AKT and ERK ½ signaling pathways and induction
of PARP cleavage.
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